Delivery Order SPE2DB22D2214-SPE2DB24FS2LZ

Award Date 10/18/23
Potential Completion Date 10/19/23
Potential Value $19K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Cosentyx 300 mg doses to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense (DoD). The contract, valued at $11,704.58, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a performance period ending on December 6, 2023 and is structured as a firm-fixed-price delivery order. This award is not designated as a set-aside contract....
This federal contract award is for the delivery of Cosentyx, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,945.89 and a completion date of May 6, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
This federal contract award is for the delivery of Cosentyx, a 300mg dosage medication, to the Defense Logistics Agency (DLA). The $26,345.88 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to deliver Cosentyx 300 mg doses in syringes. The firm-fixed-price delivery order, valued at $26,746.11, has an ultimate completion date of December 20, 2023. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for the...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $6,087.80, is for the delivery of the pharmaceutical product Cosentyx (300mg dose) and has a completion date of January 12, 2024. The contract is a Delivery Order under a Firm Fixed Price contract type. This award is not designated with a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award is for the delivery of Cosentyx 300 mg dose-2 syringes to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract has a ceiling value of $17,988.08 and an ultimate completion date of May 7, 2024. It is a firm fixed-price delivery order contract, with...
This federal contract award is for the delivery of pharmaceutical products, primarily the drug Cosentyx, to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that is a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $11,286.87 and was awarded on August 3, 2021 with an ultimate completion date of August 4, 2021. It is a firm...
This federal contract award is for the delivery of Cosentyx, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $9,131.76 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has an ultimate completion date of September 20, 2023 and does not include any set-aside designations, indicating full and open competition. Amerisourcebergen holds a significant $999,999,999...
This federal contract award is for the delivery of Cosentyx, a specialty medication, to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $8,872.15 and a completion date of January 11, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $17,265.98 firm fixed-price delivery order is for Cosentyx medication and has an ultimate completion date of April 26, 2024. The contract was awarded on April 25, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that serves as a critical supplier to various government...
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB24FS2LZ
    Delivery Order

The federal contract award is for the delivery of pharmaceutical products, specifically the medication Cosentyx 300 mg, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on October 18, 2023, with a ceiling value of $19,055.23 and an ultimate completion date of October 19, 2023. The contract is a delivery order under a Firm Fixed Price contract type.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.

Generated 5/12/25, 9:43 AM